CMS proposes coverage update for blood-derived products

(By Alia Paavola for Becker’s Hospital Review)

CMS is proposing coverage changes for certain blood-derived products and treatments.

The agency Dec. 21 proposed covering autologous platelet-rich plasma for the treatment of chronic nonhealing diabetic wounds.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org